The ZEPOSIA MS Pregnancy Registry

Multiple sclerosis can be a debilitating condition. Help future pregnant women, doctors, and researchers understand the safety of medications that can provide some relief.

Would you like to participate?
Contact the Registry today

You may be eligible if you are:

  • A resident of the United States or Canada
  • A pregnant woman diagnosed with multiple sclerosis who has:
    • Not taken any multiple sclerosis medications during pregnancy
    • Taken ZEPOSIA® (ozanimod) during pregnancy or within 3 months prior to pregnancy
    • Taken other multiple sclerosis medications during pregnancy or just prior to pregnancy

*Please note: If you have taken certain multiple sclerosis medications (e.g., Gilenya®, Mayzent®, Ponvory™, Novantrone®, Mavenclad®) prior to or during pregnancy you may not be eligible to participate. The registry staff can help determine your eligibility if you have taken these medications.

How do I participate?

Complete the Contact Request Form here and a registry staff member will contact you

Email the registry team with your contact information at:

Call the registry team toll-free at
1-877-301-9314
(hours of operation 8.30am – 5.00 pm EST)

You consent that by using one of the above methods, your personal information including name, email, or telephone number will be collected to administer your registration for the electronic consent application, at the request of Celgene, the company that will collect your data. Your personal details will be shared with CISIV, the owner of the platform for eConsent, who will process your data in line with the applicable privacy laws. More details on how your personal information is going to be protected and your privacy rights will be guaranteed are included in the informed consent form.

What is ZEPOSIA® (ozanimod)?

ZEPOSIA® (ozanimod) is a prescription medicine made by Celgene Corporation, a Bristol-Myers Squibb Company, that is used to treat relapsing forms of multiple sclerosis in adults.

Specifically, it is for the treatment of:

  • Clinically isolated syndrome
  • Relapsing-remitting disease
  • Active secondary progressive disease

Who will this study help?

Future pregnant women with multiple sclerosis, doctors, and researchers can benefit from the information you provide to the registry.

If you are eligible and would like to participate, you will be asked to:

  • Provide your consent (a requirement for participation in any research study)
  • Give the registry permission to contact your healthcare provider(s) to collect information for the study

You and your healthcare provider(s) will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms or via a short phone interview with one of the registry staff members. Only information normally documented in your medical record will be collected.

If you participate, there will be:

  • No extra doctor’s visits or additional testing
  • No changes to your existing healthcare provider(s) or care

If you are eligible and would like to participate, you will be asked to provide basic information about yourself (e.g. race, ethnicity, education, height, and weight) at enrollment.

Would you like to participate?

Enroll in the Registry